Table 1 Clinical and laboratory characteristics of coronary patients according to the presence of type 2 diabetes mellitus, and non-CAD patients
NCAD | CAD-NDM2 | P value* | CAD-DM2 | P value** | P value*** | P value | |
|---|---|---|---|---|---|---|---|
Gender, n (M/F) | 12/11 | 20/2 | 0.007 | 18/4 | 0.057 | 0.664 | 0.01 |
Age (years) | 62 ± 11 | 63 ± 11 | 0.762 | 65 ± 9 | 0.323 | 0.513 | 0.619 |
BMI (kg/m2) | 27.8 ± 5.3 | 28.2 ± 6.4 | 0.820 | 29.8 ± 5.7 | 0.229 | 0.386 | 0.481 |
LVEF (%) | 57.7 ± 12.4 | 51.7 ± 8.0 | 0.05 | 51.2 ± 4.2 | 0.024 | 0.796 | 0.031 |
Risk factors, n (%) | |||||||
Dyslipidemia | 10 (43.5) | 15 (68.2) | 0.136 | 18 (81.8) | 0.013 | 0.487 | 0.021 |
Hypertension | 21 (91.3) | 17 (77.2) | 0.242 | 20 (90.9) | 0.99 | 0.412 | 0.296 |
Current smoking | 7 (30.4) | 14 (63.6) | 0.04 | 7 (31.8) | 0.99 | 0.07 | 0.04 |
CVA | 2 (8.7) | 1 (4.5) | 0.578 | 2 (9.1) | 0.962 | 0.549 | 0.812 |
Medications, n (%) | |||||||
Aspirin | 13 (56.5) | 8 (36.4) | 0.236 | 14 (63.6) | 0.763 | 0.131 | 0.170 |
Statin | 9 (39.1) | 8 (36.4) | 0.85 | 12 (54.5) | 0.376 | 0.364 | 0.421 |
ACEI/ARB | 6 (26.1) | 5 (22.7) | 0.796 | 10 (45.4) | 0.221 | 0.202 | 0.213 |
Beta-blocker | 15 (65.2) | 8 (36.4) | 0.076 | 14 (63.6) | 0.912 | 0.131 | 0.094 |
Biochemical data | |||||||
Glucose (mg/dL) | 106.00 ± 18.93 | 103.00 ± 20.10 | 0.61 | 153.86 ± 41.51 | <0.0001 | <0.0001 | <0.0001 |
Cholesterol (mg/dL) | 161.88 ± 41.98 | 165.47 ± 30.17 | 0.74 | 143.88 ± 34.29 | 0.12 | 0.032 | 0.109 |
LDL-cholesterol (mg/dL) | 97.24 ± 31.76 | 102.95 ± 27.1 | 0.52 | 81.68 ± 23.29 | 0.068 | 0.008 | 0.04 |
HDL-cholesterol (mg/dL) | 40.70 ± 14.32 | 36.47 ± 11.43 | 0.28 | 29.75 ± 6.44 | 0.002 | 0.020 | 0.008 |
Triglycerides (mg/dL) | 119.76 ± 44.59 | 153.23 ± 61.3 | 0.041 | 187.58 ± 55.12 | <0.0001 | 0.057 | 0.0005 |
HbA1c | 5.46 ± 0.63 | 5.91 ± 0.61 | 0.02 | 7.51 ± 0.90 | <0.0001 | <0.0001 | <0.0001 |
Creatinine (mg/dL) | 1.00 ± 0.32 | 1.24 ± 0.80 | 0.16 | 1.20 ± 0.51 | 0.11 | 0.79 | 0.329 |